237 related articles for article (PubMed ID: 36683712)
1. Vibrational spectroscopy - are we close to finding a solution for early pancreatic cancer diagnosis?
Szymoński K; Chmura Ł; Lipiec E; Adamek D
World J Gastroenterol; 2023 Jan; 29(1):96-109. PubMed ID: 36683712
[TBL] [Abstract][Full Text] [Related]
2. Current Pathology Model of Pancreatic Cancer.
Szymoński K; Milian-Ciesielska K; Lipiec E; Adamek D
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565450
[TBL] [Abstract][Full Text] [Related]
3. Variabilities in global DNA methylation and β-sheet richness establish spectroscopic landscapes among subtypes of pancreatic cancer.
Szymoński K; Lipiec E; Sofińska K; Skirlińska-Nosek K; Czaja M; Seweryn S; Wilkosz N; Birarda G; Piccirilli F; Vaccari L; Chmura Ł; Szpor J; Adamek D; Szymoński M
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1792-1810. PubMed ID: 36757432
[TBL] [Abstract][Full Text] [Related]
4. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
6. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
7. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma.
Mangge H; Niedrist T; Renner W; Lyer S; Alexiou C; Haybaeck J
Curr Med Chem; 2017; 24(28):3012-3024. PubMed ID: 28494747
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic biomarkers for pancreatic cancer: An update.
Yang M; Zhang CY
World J Gastroenterol; 2021 Dec; 27(45):7862-7865. PubMed ID: 34963749
[TBL] [Abstract][Full Text] [Related]
9. Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells.
Szymoński K; Skirlińska-Nosek K; Lipiec E; Sofińska K; Czaja M; Wilkosz N; Krupa M; Wanat F; Ulatowska-Białas M; Adamek D
Anal Bioanal Chem; 2023 Dec; 415(29-30):7281-7295. PubMed ID: 37906289
[TBL] [Abstract][Full Text] [Related]
10. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
11. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
14. [Pancreatic ductal adenocarcinoma].
Gallmeier E; Gress TM
Internist (Berl); 2018 Aug; 59(8):805-822. PubMed ID: 29980819
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
16. Short report - Lethal and aggressive pancreatic cancer: molecular pathogenesis, cellular heterogeneity, and biomarkers of pancreatic ductal adenocarcinoma.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1017-1019. PubMed ID: 35179767
[TBL] [Abstract][Full Text] [Related]
17. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
Comandatore A; Balsano R; Immordino B; Arguedas D; Capula M; Baglio SR; Garajovà I; Malapelle U; Morelli L; Giovannetti E
Crit Rev Oncol Hematol; 2022 May; 173():103659. PubMed ID: 35398264
[TBL] [Abstract][Full Text] [Related]
18. Screening for early pancreatic ductal adenocarcinoma: an urgent call!
Lee MX; Saif MW
JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101
[TBL] [Abstract][Full Text] [Related]
19. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
20. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]